Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_provenance.
- NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_assertion description "[The purpose of the present study was to investigate polymorphisms related to the metabolism of fluoropyrimidine and oxaliplatin, thymidylate synthase (TS) and excision repair cross-complementing gene 1 (ERCC1) 118, in metastatic colorectal cancer patients treated with capecitabine and oxaliplatin (XELOX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_provenance.
- NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_assertion evidence source_evidence_literature NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_provenance.
- NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_assertion SIO_000772 19850635 NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_provenance.
- NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_assertion wasDerivedFrom befree-20150227 NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_provenance.
- NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_assertion wasGeneratedBy ECO_0000203 NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_provenance.